Pyruvate kinase M2 at a glance

被引:165
|
作者
Yang, Weiwei [1 ,2 ]
Lu, Zhimin [3 ,4 ,5 ,6 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, Shanghai 200031, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[6] Univ Texas Houston, Canc Biol Program, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA
基金
美国国家科学基金会;
关键词
PKM2; Pyruvate kinase M2; Metabolism reprogramming; Protein kinase; Gene transcription; TUMOR-GROWTH; PROTEIN-KINASE; NUCLEAR TRANSLOCATION; GENE-TRANSCRIPTION; CELL-PROLIFERATION; CANCER METABOLISM; PKM2; EXPRESSION; BINDING PROTEIN; ISOFORM M2; PROMOTES;
D O I
10.1242/jcs.166629
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Reprogrammed metabolism is a key feature of cancer cells. The pyruvate kinase M2 (PKM2) isoform, which is commonly upregulated in many human cancers, has been recently shown to play a crucial role in metabolism reprogramming, gene transcription and cell cycle progression. In this Cell Science at a glance article and accompanying poster, we provide a brief overview of recent advances in understanding the mechanisms underlying the regulation of PKM2 expression, enzymatic activity, metabolic functions and subcellular location. We highlight the instrumental role of the non-metabolic functions of PKM2 in tumorigenesis and evaluate the potential to target PKM2 for cancer treatment.
引用
收藏
页码:1655 / 1660
页数:6
相关论文
共 50 条
  • [41] TUMOR PYRUVATE KINASE M2 AS BIOMARKER OF ESOPHAGEAL CANCER AND GERD
    Gupta, Tarun
    Sambyal, Vasudha
    ANNALS OF ONCOLOGY, 2011, 22 : v28 - v28
  • [42] TUMOR PYRUVATE KINASE M2 AS BIOMARKER OF ESOPHAGEAL CANCER AND GERD
    Gupta, T.
    ANNALS OF ONCOLOGY, 2010, 21 : 41 - 41
  • [43] Rare diseases and pyruvate kinase M2: a promising therapeutic connection
    Kapoor, Saumya
    Kalmegh, Vaishnavi
    Kumar, Hemant
    Mandoli, Amit
    Shard, Amit
    DRUG DISCOVERY TODAY, 2024, 29 (05)
  • [44] Nanoscale metal organic frameworks inhibition of pyruvate kinase of M2
    Xiangling Ren
    Xinyuan Huang
    Qiong Wu
    Longfei Tan
    Changhui Fu
    Yi Chen
    Xianwei Meng
    Chinese Chemical Letters, 2021, 32 (10) : 3087 - 3089
  • [45] Protein Stability of Pyruvate Kinase Isozyme M2 Is Mediated by HAUSP
    Choi, Hae-Seul
    Pei, Chang-Zhu
    Park, Jun-Hyeok
    Kim, Soo-Yeon
    Song, Seung-Yeon
    Shin, Gyeong-Jin
    Baek, Kwang-Hyun
    CANCERS, 2020, 12 (06) : 1 - 15
  • [46] Serine is a natural ligand and allosteric activator of pyruvate kinase M2
    Chaneton, Barbara
    Hillmann, Petra
    Zheng, Liang
    Martin, Agnes C. L.
    Maddocks, Oliver D. K.
    Chokkathukalam, Achuthanunni
    Coyle, Joseph E.
    Jankevics, Andris
    Holding, Finn P.
    Vousden, Karen H.
    Frezza, Christian
    O'Reilly, Marc
    Gottlieb, Eyal
    NATURE, 2012, 491 (7424) : 458 - +
  • [47] Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2
    Claudia Abbruzzese
    Silvia Matteoni
    Paola Matarrese
    Michele Signore
    Barbara Ascione
    Elisabetta Iessi
    Aymone Gurtner
    Andrea Sacconi
    Lucia Ricci-Vitiani
    Roberto Pallini
    Andrea Pace
    Veronica Villani
    Andrea Polo
    Susan Costantini
    Alfredo Budillon
    Gennaro Ciliberto
    Marco G. Paggi
    Cell Death & Disease, 14
  • [48] Pyruvate kinase isoenzyme M2 shows increased expression in diabetes
    Vittas, S.
    Kopf, S.
    Volk, N.
    Hidmark, A.
    Oikonomou, D.
    Fleming, T. H.
    Nawroth, P. P.
    DIABETOLOGIA, 2014, 57 : S532 - S532
  • [49] Activating Pyruvate Kinase M2 to Prevent the Development of Diabetic Nephropathy
    Qi, Weier
    Kannt, Aimo
    Sadowski, Thorsten
    Li, Qian
    Atsushi, Ishikado
    Wu, I-Hsien
    Lockhart, Samuel
    Yorek, Mark A.
    Liew, Chong Wee
    Stillman, Issac
    Tinsley, Liane
    Pober, David
    Stanton, Robert
    Feener, Edward
    Keenan, Hillary
    King, George L.
    DIABETES, 2017, 66 : A99 - A99
  • [50] M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth
    Cortes-Cros, Marta
    Hemmerlin, Christelle
    Ferretti, Stephane
    Zhang, Juan
    Gounarides, John S.
    Yin, Hong
    Muller, Alban
    Haberkorn, Anne
    Chene, Patrick
    Sellers, William R.
    Hofmann, Francesco
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (02) : 489 - 494